Baxter Nicholas W 4
4 · Lexaria Bioscience Corp. · Filed May 16, 2025
Insider Transaction Report
Form 4
Baxter Nicholas W
Director
Transactions
- Award
Stock Options
2025-05-15+11,000→ 63,000 totalExercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (11,000 underlying)
Holdings
- 6,500
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying) - 8,400
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (1,900 underlying) - 11,800
Stock Options
Exercise: $3.39From: 2022-03-08Exp: 2027-03-08→ Common Shares (3,400 underlying) - 30,000
Stock Options
Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (18,200 underlying) - 52,000
Stock Options
Exercise: $3.39From: 2024-07-26Exp: 2029-07-26→ Common Shares (12,000 underlying) - 11,000
common shares
- 1,500
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying) - 35,000
Stock Options
Exercise: $0.87From: 2023-07-25Exp: 2028-07-25→ Common Shares (5,000 underlying) - 40,000
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (5,000 underlying)